{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:15:31Z","timestamp":1784783731955,"version":"3.55.0"},"reference-count":73,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Recurrent Campylobacter enteritis is a well-recorded complication of primary hypogammaglobulinemia but has only rarely been reported with other types of immunodeficiency, and no cases have been reported after rituximab-associated secondary hypogammaglobulinemia. We therefore reviewed our local microbiology laboratory databases and conducted a literature search, to provide a detailed characterization of the immunodeficiency states associated with recurrent Campylobacter enteritis. Published cases had primary hypogammaglobulinemia, most frequently in the setting of common variable immunodeficiency, x-linked agammaglobulinemia, and Good syndrome. No cases were identified in the literature after rituximab or secondary hypogammaglobulinemia. We report a 73-year-old patient with recurrent Campylobacter enteritis and hypogammaglobulinemia in the setting of non-Hodgkin lymphoma, chemotherapy, and maintenance rituximab. Physicians should be aware of the association of recurrent Campylobacter enteritis and immunodeficiency, most commonly in primary hypogammaglobulinemia. Rituximab alone may not be sufficiently immunosuppressive for recurrent campylobacteriosis to occur; additional factors, including hematological malignancy and its treatment, appear necessary. Patients with recurrent Campylobacter enteritis and those starting rituximab should be investigated for hypogammaglobulinemia and B-lymphopenia.<\/jats:p>","DOI":"10.3390\/jcm9020553","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T08:12:22Z","timestamp":1582618342000},"page":"553","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Recurrent Campylobacter Enteritis in Patients with Hypogammaglobulinemia: Review of the Literature"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-002X","authenticated-orcid":false,"given":"Iris","family":"Najjar","sequence":"first","affiliation":[{"name":"University Department of Medicine, Kantonsspital Baselland, Bruderholz, University of Basel, 4101 Bruderholz, Switzerland"},{"name":"Infectious Diseases Service, Kantonsspital Baselland, Bruderholz, University of Basel, 4101 Bruderholz, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florina","family":"Paluca","sequence":"additional","affiliation":[{"name":"University Department of Medicine, Kantonsspital Baselland, Bruderholz, University of Basel, 4101 Bruderholz, Switzerland"},{"name":"Department of Medicine, Luzerner Kantonsspital, 6004 Luzern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Loukidis","sequence":"additional","affiliation":[{"name":"University Department of Medicine, Kantonsspital Baselland, Bruderholz, University of Basel, 4101 Bruderholz, Switzerland"},{"name":"Hematology Service, Kantonsspital Baselland, Bruderholz, University of Basel, 4101 Bruderholz, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1488-5407","authenticated-orcid":false,"given":"Philip E.","family":"Tarr","sequence":"additional","affiliation":[{"name":"University Department of Medicine, Kantonsspital Baselland, Bruderholz, University of Basel, 4101 Bruderholz, Switzerland"},{"name":"Infectious Diseases Service, Kantonsspital Baselland, Bruderholz, University of Basel, 4101 Bruderholz, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1086\/587669","article-title":"Infections in 252 patients with common variable immunodeficiency","volume":"46","author":"Oksenhendler","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3181f2638d","article-title":"Campylobacter bacteremia: Clinical characteristics, incidence, and outcome over 23 years","volume":"89","author":"Mohedano","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.1097\/INF.0b013e31829baae0","article-title":"Demographic and clinical characteristics of Campylobacter bacteremia in children with and without predisposing factors","volume":"32","author":"Carmi","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Arsenault, J., Ravel, A., Michel, P., Berke, O., and Gosselin, P. (2011). Do patients with recurrent episodes of campylobacteriosis differ from those with a single disease event?. BMC Public Health, 11.","DOI":"10.1186\/1471-2458-11-32"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/BF01960888","article-title":"Erysipelas-like skin lesions associated with Campylobacter jejuni septicemia in patients with hypogammaglobulinemia","volume":"11","author":"Kerstens","year":"1992","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02098467","article-title":"Use of an immunoglobulin M containing preparation for treatment of two hypogammaglobulinemic patients with persistent Campylobacter jejuni infection","volume":"12","author":"Borleffs","year":"1993","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.5694\/j.1326-5377.1986.tb139451.x","article-title":"Campylobacter bacteraemia: A report of 10 cases","volume":"145","author":"Spelman","year":"1986","journal-title":"Med. J. Aust."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Hopkins, S., Abuzakouk, M., Brannigan, E., Bergin, C., and Feighery, C. (2011). Campylobacter jejuni cellulitis in a patient with pan-hypogammaglobulinaemia. BMJ Case Rep.","DOI":"10.1136\/bcr.02.2010.2741"},{"key":"ref_10","first-page":"735108","article-title":"Relapsing Campylobacter jejuni Systemic Infections in a Child with X-Linked Agammaglobulinemia","volume":"2013","author":"Ariganello","year":"2013","journal-title":"Case Rep. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2169\/internalmedicine.0312-17","article-title":"Emergence of Carbapenem Non-susceptible Campylobacter coli after Long-term Treatment against Recurrent Bacteremia in a Patient with X-linked Agammaglobulinemia","volume":"57","author":"Hagiya","year":"2018","journal-title":"Intern Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.inf.0000130080.86862.d5","article-title":"Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient","volume":"23","author":"Tokuda","year":"2004","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2169\/internalmedicine.46.6108","article-title":"Relapsing Campylobacter coli bacteremia with reactive arthritis in a patient with X-linked agammaglobulinemia","volume":"46","author":"Arai","year":"2007","journal-title":"Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/clinids\/23.2.526","article-title":"An unusual case of refractory Campylobacter jejuni infection in a patient with X-linked agammaglobulinemia: Successful combined therapy with maternal plasma and ciprofloxacin","volume":"23","author":"Autenrieth","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1081-1206(10)62036-4","article-title":"An unusual case of Campylobacter jejuni pericarditis in a patient with X-linked agammaglobulinemia","volume":"89","author":"Rafi","year":"2002","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10875-017-0474-7","article-title":"IgM Augments Complement Bactericidal Activity with Serum from a Patient with a Novel CD79a Mutation","volume":"38","author":"Langereis","year":"2018","journal-title":"J. Clin. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF02214947","article-title":"Campylobacter jejuni arthritis in secondary amyloidosis","volume":"14","author":"Simon","year":"1995","journal-title":"Clin. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.0954-6820.1983.tb03709.x","article-title":"Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia","volume":"213","author":"Tilvis","year":"1983","journal-title":"Acta Med. Scand."},{"key":"ref_19","first-page":"752","article-title":"Campylobacter enteritis in normal and immunodeficient children","volume":"137","author":"Melamed","year":"1983","journal-title":"Am. J. Dis. Child."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-100-6-832","article-title":"Persistent Campylobacter jejuni infection in an immunocompromised patient","volume":"100","author":"Johnson","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/0003-4819-108-4-540","article-title":"Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV)","volume":"108","author":"Perlman","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archinte.1984.00350170240038","article-title":"Jejunal infection with Campylobacter","volume":"144","author":"Ward","year":"1984","journal-title":"Arch. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-96-2-187","article-title":"Campylobacter enteritis in immune-deficient patients","volume":"96","author":"Ahnen","year":"1982","journal-title":"Ann. Intern. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1128\/AAC.00447-16","article-title":"Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis","volume":"60","author":"Pigrau","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","first-page":"e41","article-title":"Recurrent Campylobacter Bacteremia as the First Manifestation of Hypogammaglobulinemia: A Case Report and Literature Review","volume":"51","author":"Gharamti","year":"2019","journal-title":"J. Infect. Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s10096-010-0999-7","article-title":"Campylobacter jejuni bacteremia and Helicobacter pylori in a patient with X-linked agammaglobulinemia","volume":"29","author":"Claas","year":"2010","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/infdis\/152.5.1099","article-title":"Hypogammaglobulinemia and recurrent Campylobacter jejuni infection","volume":"152","author":"LeBar","year":"1985","journal-title":"J. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0163-4453(86)94190-3","article-title":"Campylobacter jejuni bacteraemia as a cause of recurrent fever in a patient with hypogammaglobulinaemia","volume":"12","author":"Mouton","year":"1986","journal-title":"J. Infect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e7238","DOI":"10.1097\/MD.0000000000007238","article-title":"Recurrent Campylobacter jejuni bacteremia in a patient with hypogammaglobulinemia: A case report","volume":"96","author":"Kim","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00005792-200103000-00005","article-title":"Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature","volume":"80","author":"Tarr","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1078\/1438-4221-00099","article-title":"Investigation of infection with Campylobacter jejuni in a man with hypogammaglobulinaemia using PCR-single-stranded conformational polymorphism (PCR-SSCP) typing","volume":"291","author":"Moore","year":"2001","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/bmj.288.6416.531","article-title":"Chronic campylobacter colitis and uveitis in patient with hypogammaglobulinaemia","volume":"288","author":"Lever","year":"1984","journal-title":"Br. Med. J. (Clin. Res. Ed.)"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1093\/qjmed\/hcu094","article-title":"Hypogammaglobulinaemia after rituximab treatment-incidence and outcomes","volume":"107","author":"Makatsori","year":"2014","journal-title":"QJM"},{"key":"ref_34","unstructured":"World Health Organization WHO (2012). The Global View of CAMPYLOBACTERIOSIS, World Health Organization WHO. Available online: www.who.int\/iris\/bitstream\/10665\/80751\/1\/9789241564601_eng.pdf."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1155\/2006\/806874","article-title":"Estimated Numbers of Community Cases of Illness Due to Salmonella, Campylobacter and Verotoxigenic Escherichia Coli: Pathogen-specific Community Rates","volume":"17","author":"Thomas","year":"2006","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/MCG.0b013e318206bdb8","article-title":"High prevalence of intestinal carriage of Campylobacter coli in patients with primary antibody deficiencies: A silent infection that could shift to a life-threatening condition","volume":"45","author":"Dionisi","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mib.2006.11.005","article-title":"Persistent bacterial infections and primary immune disorders","volume":"10","author":"Freeman","year":"2007","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1128\/JCM.39.1.14-23.2001","article-title":"Multilocus sequence typing system for Campylobacter jejuni","volume":"39","author":"Dingle","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1128\/CDLI.8.2.314-319.2001","article-title":"Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients","volume":"8","author":"Strid","year":"2001","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/CMR.00055-07","article-title":"Host-pathogen interactions in Campylobacter infections: The host perspective","volume":"21","author":"Janssen","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1286-4579(99)80520-6","article-title":"Pathophysiology of Campylobacter jejuni infections of humans","volume":"1","author":"Wassenaar","year":"1999","journal-title":"Microbes Infect."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1017\/S0950268800056466","article-title":"Campylobacter diarrhoea and an association of recent disease with asymptomatic shedding in Egyptian children","volume":"106","author":"Pazzaglia","year":"1991","journal-title":"Epidemiol. Infect."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1016\/j.vaccine.2006.05.085","article-title":"Novel surface polypeptides of Campylobacter jejuni as traveller\u2019s diarrhoea vaccine candidates discovered by proteomics","volume":"24","author":"Prokhorova","year":"2006","journal-title":"Vaccine"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/0002-9343(86)90646-7","article-title":"Persistence of multiply antibiotic-resistant Campylobacter jejuni in a patient with the acquired immune deficiency syndrome","volume":"80","author":"Dworkin","year":"1986","journal-title":"Am. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3476(05)82652-6","article-title":"Protection of breast-fed infants against Campylobacter diarrhea by antibodies in human milk","volume":"116","author":"Calva","year":"1990","journal-title":"J. Pediatr."},{"key":"ref_46","first-page":"1363","article-title":"Combined Treatment with Oral Kanamycin and Parenteral Antibiotics for a Case of Persistent Bacteremia and Intestinal Carriage with Campylobacter coli","volume":"47","author":"Okada","year":"2008","journal-title":"Intern. Med. Jpn. Soc. Intern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.27609","article-title":"Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?","volume":"61","author":"Lok","year":"2015","journal-title":"Hepatology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.2015.2571","article-title":"Preventing hepatitis B reactivation due to immunosuppressive drug treatments","volume":"313","author":"Perrillo","year":"2015","journal-title":"JAMA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M15-1121","article-title":"Hepatitis B Virus Reactivation and Prophylaxis During Solid Tumor Chemotherapy: A Systematic Review and Meta-analysis","volume":"164","author":"Paul","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1136\/ard.2010.144998","article-title":"Rituximab Consensus Expert Committee Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis","volume":"70","author":"Buch","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.clml.2012.11.011","article-title":"Incidence of hypogammaglobulinemia in patients receiving rituximab and the use of intravenous immunoglobulin for recurrent infections","volume":"13","author":"Casulo","year":"2013","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1002\/art.23059","article-title":"Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: An open-label extension analysis","volume":"56","author":"Keystone","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/annrheumdis-2012-201956","article-title":"Long-term safety of rituximab in rheumatoid arthritis: 9.5-year follow-up of the global clinical trial programme with a focus on adverse events of interest in RA patients","volume":"72","author":"Emery","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"ref_55","unstructured":"(2019, January 31). Available online: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/mabthera-epar-product-information_en.pdf."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.autrev.2017.11.015","article-title":"Clinical and microbiological characteristics of the infections in patients treated with rituximab for autoimmune and\/or malignant hematological disorders","volume":"17","author":"Tudesq","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.seminhematol.2010.01.002","article-title":"Rituximab-associated infections","volume":"47","year":"2010","journal-title":"Semin. Hematol."},{"key":"ref_58","first-page":"628902","article-title":"Campylobacter fetus Bacteremia Revealed by Cellulitis without Gastrointestinal Symptoms in the Context of Acquired Hypogammaglobulinemia: A Report of Three Cases","volume":"2011","author":"Brah","year":"2011","journal-title":"Case Rep. Gastrointest. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/annrheumdis-2011-200719","article-title":"Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab","volume":"71","author":"Meyer","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_60","first-page":"110","article-title":"Successful conservative management of campylobacter cholecystitis occurring post chemotherapy and rituximab: A rare disease entity","volume":"128","author":"Gupta","year":"2015","journal-title":"N. Z. Med. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.2169\/internalmedicine.1031-18","article-title":"Successful Empiric Therapy for Postsplenectomy Sepsis with Campylobacter fetus in an Abattoir Worker with Follicular Lymphoma","volume":"57","author":"Nakazawa","year":"2018","journal-title":"Intern. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1182\/blood.V110.11.1288.1288","article-title":"Predictive Factors to Hypogammaglobulinemia and Non-Neutropenic Infection Complications after Rituximab\/Chemotherapy Treatment","volume":"110","author":"Filanovsky","year":"2007","journal-title":"Blood"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: Half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/annonc\/mdl141","article-title":"High incidence of non-neutropenic infections induced by rituximab plus fludarabine and associated with hypogammaglobulinemia: A frequently unrecognized and easily treatable complication","volume":"17","author":"Cabanillas","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-0609.2008.01174.x","article-title":"FCGR3A-158V\/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin\u2019s lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation","volume":"82","author":"Nishio","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/08830185.2017.1346092","article-title":"Risk factors predisposing to the development of hypogammaglobulinemia and infections post-Rituximab","volume":"36","author":"Christou","year":"2017","journal-title":"Int. Rev. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jaci.2015.06.035","article-title":"Continuing IgG replacement therapy for hypogammaglobulinemia after rituximab--for how long?","volume":"136","author":"Barmettler","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3899\/jrheum.090856","article-title":"Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials","volume":"37","author":"Emery","year":"2010","journal-title":"J. Rheumatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/jcp.2009.068940","article-title":"Does rituximab aggravate pre-existing hypogammaglobulinaemia?","volume":"63","author":"Diwakar","year":"2010","journal-title":"J. Clin. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Mogensen, T.H., Bernth-Jensen, J.M., Petersen, C.C., Petersen, M.S., Nyvold, C., Gadegaard, K.H., Hokland, M., Hokland, P., and Larsen, C.S. (2013). Common variable immunodeficiency unmasked by treatment of immune thrombocytopenic purpura with Rituximab. BMC Blood Disord., 13.","DOI":"10.1186\/2052-1839-13-4"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jaip.2014.06.003","article-title":"Rituximab and immune deficiency: Case series and review of the literature","volume":"2","author":"Kaplan","year":"2014","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e184169","DOI":"10.1001\/jamanetworkopen.2018.4169","article-title":"Association of Immunoglobulin Levels, Infectious Risk, and Mortality With Rituximab and Hypogammaglobulinemia","volume":"1","author":"Barmettler","year":"2018","journal-title":"JAMA Netw. Open"},{"key":"ref_73","first-page":"1","article-title":"Common Variable Immunodeficiency: Clinical and Immunological Features of 248 Patients","volume":"92","author":"Carol","year":"1999","journal-title":"Clin. Immunol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/2\/553\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:58:48Z","timestamp":1760173128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/2\/553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":73,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["jcm9020553"],"URL":"https:\/\/doi.org\/10.3390\/jcm9020553","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]}}}